EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieValidierungsstudieOpen Access · CC BY-NC 4.0

Sensitive and Specific Droplet Digital PCR Assays for Circulating Tumor HPV DNA: Development, Validation, and Clinical Application in HPV-Associated Cancers

Alvida Qvick iD, Elin Andersson, Anna Oldaeus Almerén, Max Waenerlund, Bianca Stenmark, Christina Karlsson, Mats G Karlsson, Gisela Helenius

Molecular Diagnosis & Therapy · 2024

DOI: 10.1007/s40291-024-00743-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Molecular Diagnosis & Therapy, 2024. Verfasst von Alvida Qvick und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. alvida.qvick@regionorebrolan.com. Hauptthemen laut MEDLINE: Circulating Tumor DNA, DNA, Viral, Papillomavirus Infections, Polymerase Chain Reaction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Örebro County Council Research committee, Nyckelfonden-Örebro University Hospital Research Foundation, Lions fund for cancer research Uppsala-Örebro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Human papillomavirus (HPV) has emerged as a significant contributor to cancer incidence globally, particularly in the context of oropharyngeal squamous cell carcinoma (OPSCC) and cancer of unknown primary (HNCUP). This study aimed to develop and validate droplet digital PCR (ddPCR) assays for the detection of circulating tumor HPV DNA (ctHPV-DNA) in plasma, focusing on high-risk HPV genotypes associated with these cancers. METHODS: ddPCR assays for HPV16, 18, 33, 35, 56, and 59 were developed and tested using gBlocks, HPV cell-free DNA, fragmented tumor HPV+ DNA, and plasma samples from patients with HPV+ OPSCC (n = 110) and HNCUP (n = 9). RESULTS: Assays demonstrated robust technical sensitivity across all tested HPV genotypes. Clinical application of the assays on a cohort of patients with HPV+ OPSCC and HNCUP revealed high sensitivity (91.6%) and wide variability in ctHPV-DNA levels. Analyses revealed correlations between ctHPV-DNA levels and TNM stage and tumor viral load. The association between ctHPV-DNA and tumor viral load persisted even after adjusting for TNM stage. At posttreatment, 72.5% of samples had reached undetectable ctHPV-DNA levels. Having detectable ctHPV-DNA posttreatment was associated with a higher ctHPV-DNA level at diagnosis and higher viral load at diagnosis. CONCLUSION: The findings underscore the potential of ctHPV-DNA as a biomarker for monitoring HPV+ cancers and offer insights into tumor dynamics. Implementation of these assays in clinical practice could enhance no-invasive treatment monitoring and recurrence detection in HPV-associated cancers. CLINICAL TRIALS: NCT05904327.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating Tumor DNADNA, ViralPapillomavirus InfectionsPolymerase Chain ReactionAdultAgedFemaleHumansMaleMiddle AgedGenotypeNeoplasms, Unknown PrimaryOropharyngeal NeoplasmsPapillomaviridaeSensitivity and Specificity

Substanzen

Circulating Tumor DNADNA, Viral

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. alvida.qvick@regionorebrolan.com.
  • Clinical Research Center, Örebro University Hospital, Örebro, Sweden.
  • Department of Otolaryngology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Department of Otolaryngology, Sahlgrenska University Hospital, Göteborg, Sweden.
  • Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

ORCID-Profile: Alvida Qvick

Förderung

  • Örebro County Council Research committee
  • Nyckelfonden-Örebro University Hospital Research Foundation
  • Lions fund for cancer research Uppsala-Örebro
  • Örebro University

Zitieren

APA

Qvick, A., Andersson, E., Oldaeus Almerén, A., Waenerlund, M., Stenmark, B., Karlsson, C., Karlsson, M. G., & Helenius, G. (2024). Sensitive and Specific Droplet Digital PCR Assays for Circulating Tumor HPV DNA: Development, Validation, and Clinical Application in HPV-Associated Cancers. Molecular Diagnosis & Therapy. https://doi.org/10.1007/s40291-024-00743-9

Vancouver

Qvick A, Andersson E, Oldaeus Almerén A, Waenerlund M, Stenmark B, Karlsson C, et al. Sensitive and Specific Droplet Digital PCR Assays for Circulating Tumor HPV DNA: Development, Validation, and Clinical Application in HPV-Associated Cancers. Molecular Diagnosis & Therapy. 2024. doi:10.1007/s40291-024-00743-9

BibTeX
@article{Qvick2024,
  author = {Qvick, Alvida and Andersson, Elin and Oldaeus Almerén, Anna and Waenerlund, Max and Stenmark, Bianca and Karlsson, Christina and Karlsson, Mats G and Helenius, Gisela},
  title = {Sensitive and Specific Droplet Digital PCR Assays for Circulating Tumor HPV DNA: Development, Validation, and Clinical Application in HPV-Associated Cancers},
  journal = {Molecular Diagnosis & Therapy},
  year = {2024},
  doi = {10.1007/s40291-024-00743-9}
}
Kostenlos starten →